Does KETOROLAC TROMETHAMINE Cause Malignant neoplasm progression? 9 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Malignant neoplasm progression have been filed in association with KETOROLAC TROMETHAMINE (ketorolac tromethamine). This represents 0.2% of all adverse event reports for KETOROLAC TROMETHAMINE.
9
Reports of Malignant neoplasm progression with KETOROLAC TROMETHAMINE
0.2%
of all KETOROLAC TROMETHAMINE reports
1
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From KETOROLAC TROMETHAMINE?
Of the 9 reports, 1 (11.1%) resulted in death, 7 (77.8%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KETOROLAC TROMETHAMINE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does KETOROLAC TROMETHAMINE Cause?
Drug ineffective (1,172)
Drug hypersensitivity (838)
Treatment failure (776)
Off label use (593)
Nausea (501)
Hyperhidrosis (353)
Product use in unapproved indication (328)
Nightmare (325)
Sedation (319)
Dyspnoea (244)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which KETOROLAC TROMETHAMINE Alternatives Have Lower Malignant neoplasm progression Risk?
KETOROLAC TROMETHAMINE vs KETOROLAC\KETOROLAC TROMETHAMINE
KETOROLAC TROMETHAMINE vs KETOTIFEN
KETOROLAC TROMETHAMINE vs KLONOPIN
KETOROLAC TROMETHAMINE vs L-ASPARAGINASE
KETOROLAC TROMETHAMINE vs LABETALOL